Literature DB >> 17325084

Absence of tooth staining with doxycycline treatment in young children.

Benjamin Volovitz1, Ronit Shkap, Jacob Amir, Shlomo Calderon, Izhak Varsano, Moshe Nussinovitch.   

Abstract

The aim of the study was to determine if doxycycline causes tooth staining in young children. A dentist examined 31 randomized children who had been treated with doxycycline and 30 children who had not received doxycycline. Mean age of the children was 10.4 -/+ 2.1 years. Mean age at receipt of the first doxycycline treatment was 4.1 -/+ 1.6 years, and mean number of doxycycline courses was 2.0 -/+ 1.3. No tooth staining was detected by the dentist in any of the children in either group. These findings indicate that treatment with doxycycline in children aged 2 to 8 years is not associated with tooth staining.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17325084     DOI: 10.1177/0009922806290026

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  24 in total

1.  Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy.

Authors:  Arvind Shergill; Philip John; Joao G Amaral
Journal:  Pediatr Radiol       Date:  2012-05-31

Review 2.  Human granulocytic anaplasmosis.

Authors:  Johan S Bakken; J Stephen Dumler
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

3.  Increasing Incidence of Ehrlichiosis in the United States: A Summary of National Surveillance of Ehrlichia chaffeensis and Ehrlichia ewingii Infections in the United States, 2008-2012.

Authors:  Kristen Nichols Heitman; F Scott Dahlgren; Naomi A Drexler; Robert F Massung; Casey Barton Behravesh
Journal:  Am J Trop Med Hyg       Date:  2015-11-30       Impact factor: 2.345

4.  In vitro and in vivo antimalarial efficacies of optimized tetracyclines.

Authors:  Michael P Draper; Beena Bhatia; Haregewein Assefa; Laura Honeyman; Lynne K Garrity-Ryan; Atul K Verma; Jiri Gut; Kelley Larson; Janice Donatelli; Ann Macone; Kevin Klausner; Raina G Leahy; Aleksandrs Odinecs; Kwasi Ohemeng; Philip J Rosenthal; Mark L Nelson
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

5.  Self-reported treatment practices by healthcare providers could lead to death from Rocky Mountain spotted fever.

Authors:  Jillian Zientek; F Scott Dahlgren; Jennifer H McQuiston; Joanna Regan
Journal:  J Pediatr       Date:  2013-11-16       Impact factor: 4.406

6.  Fatal Rocky Mountain spotted fever in the United States, 1999-2007.

Authors:  F Scott Dahlgren; Robert C Holman; Christopher D Paddock; Laura S Callinan; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2012-04       Impact factor: 2.345

7.  Pediatric anthrax clinical management.

Authors:  John S Bradley; Georgina Peacock; Steven E Krug; William A Bower; Amanda C Cohn; Dana Meaney-Delman; Andrew T Pavia
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

8.  Hollow-fiber pharmacodynamic studies and mathematical modeling to predict the efficacy of amoxicillin for anthrax postexposure prophylaxis in pregnant women and children.

Authors:  Arnold Louie; Brian Vanscoy; Weiguo Liu; Robert Kulawy; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

9.  National Surveillance of Spotted Fever Group Rickettsioses in the United States, 2008-2012.

Authors:  Naomi A Drexler; F Scott Dahlgren; Kristen Nichols Heitman; Robert F Massung; Christopher D Paddock; Casey Barton Behravesh
Journal:  Am J Trop Med Hyg       Date:  2015-08-31       Impact factor: 2.345

10.  Is Doxycycline Appropriate for Routine Treatment of Young Children With Erythema Migrans?

Authors:  Gary P Wormser; Franc Strle; Eugene D Shapiro
Journal:  Pediatr Infect Dis J       Date:  2019-11       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.